Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Afzaljavan, Fahimeh

  • Google
  • 2
  • 11
  • 18

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2020The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and Breast Cancer Risk7citations
  • 2019The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk11citations

Places of action

Chart of shared publication
Vahednia, Elham
2 / 2 shared
Rivandi, Mahdi
1 / 1 shared
Ghasemian, Saeed Zarif
1 / 1 shared
Tehrani, Negin Chaeichi
1 / 1 shared
Abavisani, Mohammad
1 / 1 shared
Khayami, Reza
1 / 1 shared
Bagherabad, Matineh Barati
1 / 1 shared
Shandiz, Fatemeh Homaei
1 / 1 shared
Moezzi, Atefeh
1 / 1 shared
Kooshyar, Mohammad Mahdi
1 / 1 shared
Tajbakhsh, Amir
1 / 3 shared
Chart of publication period
2020
2019

Co-Authors (by relevance)

  • Vahednia, Elham
  • Rivandi, Mahdi
  • Ghasemian, Saeed Zarif
  • Tehrani, Negin Chaeichi
  • Abavisani, Mohammad
  • Khayami, Reza
  • Bagherabad, Matineh Barati
  • Shandiz, Fatemeh Homaei
  • Moezzi, Atefeh
  • Kooshyar, Mohammad Mahdi
  • Tajbakhsh, Amir
OrganizationsLocationPeople

article

The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk

  • Vahednia, Elham
  • Bagherabad, Matineh Barati
  • Shandiz, Fatemeh Homaei
  • Afzaljavan, Fahimeh
  • Moezzi, Atefeh
  • Kooshyar, Mohammad Mahdi
  • Tajbakhsh, Amir
Abstract

<p>To investigate the association of rs1045485 and rs10931936 in caspase 8 (CASP8) and their haplotypes with molecular profile as well as breast cancer in Iran, 287 breast cancer patients and 490 healthy women were genotype using the amplification refractory mutation system and polymerase chain reaction restriction fragment length polymorphism. Results indicated a protective effect for CC genotype of rs1045485 and the decrease risk of breast cancer for C-C haplotype of rs10931936-rs104548 in CASP8.</p><p>Introduction: Single nucleotide polymorphisms account for most genetic predispositions to breast cancer in the general population. Because of the lack of studies concerning the 2 common polymorphisms in caspase 8 (CASP8), namely rs104548 and rs10931936 in Iranian population, we evaluated the association of these 2 polymorphisms and their haplotypes with breast cancer and molecular profile. Materials and Method: Blood samples were collected from 287 breast cancer patients and 490 controls. Genotyping of rs1045485 and rs10931936 was conducted using an amplification refractory mutation system and polymerase chain reaction restriction fragment length polymorphism, respectively. PHASE version 2 (Matthew Stephens) was used to estimate the frequencies of haplotypes. Statistical analysis was performed using SPSS 16.0 (SPSS Inc). Results: Although hormone receptors and the molecular profile did not indicate any significant association with different genotypes (P &gt; .05), patients with CC genotype of rs1045485 were more likely to have HER2-positive breast cancer than those with GG genotype (odds ratio [OR], 2.93; 95% confidence interval [CI], 1.04-8.26). In addition, CC genotype of D302H was associated with a decreased risk of breast cancer to 48% (OR, 0.52; 95% CI, 0.30-0.90) whereas no significant association was found between rs10931936 and breast cancer. Haplotype analysis indicated C-C haplotype is associated with the decreased risk of breast cancer (OR, 0.69; 95% CI, 0.52-0.91). Conclusion: Our data showed a protective effect for CC genotype of rs1045485 variant and C-C haplotype of rs10931936-rs104548 in CASP8 in association with the decrease risk of breast cancer whereas rs10931936 showed no significant association. CASP8 rs1045485 polymorphism might be a candidate genetic marker to evaluate risk of breast cancer. However, further larger studies can confirm such findings. (C) 2019 Elsevier Inc. All rights reserved.</p>

Topics
  • impedance spectroscopy
  • phase
  • refractory
  • chemical ionisation